Skip to main content
. 2022 Dec 13;13:1090958. doi: 10.3389/fneur.2022.1090958

Figure 1.

Figure 1

The levels of HCY in serum (A), methylmalonic acid in urine (B), methylmalonic acid in serum (C), methylmalonic acid in serum total exosomes (D), and methylmalonic acid in serum neuro-exosomes (E) in different groups. HCY, homocysteine; MMA, methylmalonic acidemia; CNT, Control; HHcy, non-inherited hyperhomocysteinemia; neuro-exosomes, neuronal-derived exosomes; MMA-normal, cblC type methylmalonic acidemia patients with normal IQ or DQ; MMA-mild cognitive impairment, cblC type methylmalonic acidemia patients with mild cognitive impairment; MMA-moderate cognitive impairment, cblC type methylmalonic acidemia patients with moderate cognitive impairment; MMA-severe cognitive impairment, cblC type methylmalonic acidemia patients with severe cognitive impairment.